CanSino Biologics Inc. has filed an updated list of directors and their respective roles with the Hong Kong Stock Exchange. The board comprises Dr. Xuefeng Yu (Chairman, Executive Director), Dr. Shou Bai Chao (Executive Director), Ms. Jing Wang (Executive Director), Mr. Chi Shing Li (Non-executive Director), Mr. Yiu Leung Andy Cheung (Independent Non-executive Director), Mr. Man Cho (Independent Non-executive Director), and Ms. Xuefeng Ji (Independent Non-executive Director). Committee appointments are as follows: Dr. Xuefeng Yu serves as a member of both the Remuneration and Assessment Committee and the Nomination Committee. Mr. Chi Shing Li is a member of the Audit Committee and the Remuneration and Assessment Committee. Mr. Yiu Leung Andy Cheung chairs the Audit Committee and is a member of the Remuneration and Assessment Committee. Mr. Man Cho chairs the Remuneration and Assessment Committee and is a member of the Nomination Committee. Ms. Xuefeng Ji is a member of the Audit Committee and the Remuneration and Assessment Committee, and serves as Chairwoman of the Nomination Committee. Dr. Shou Bai Chao and Ms. Jing Wang do not serve on any board committees.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cansino Biologics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251127-11931119), on November 27, 2025, and is solely responsible for the information contained therein.
Comments